The Morcellators Market refers to the global industry that develops, manufactures, and sells surgical morcellator devices used in minimally invasive laparoscopic procedures to cut and extract tissue or organs, such as the uterus and fibroids. Driven by the growing demand for minimally invasive surgeries, the rising prevalence of uterine fibroids, and advancements in contained morcellation systems addressing FDA safety regulations, the market serves hospitals, ambulatory surgical centers, and specialty clinics worldwide.
According to FutureWise analysis, the Morcellators market in 2026 is US$165.22 million, and is expected to reach US$298.43 million by 2036 at a CAGR of 7.34%. The market's growth is driven by the increasing prevalence of uterine fibroids and benign uterine conditions that require surgery. In the U.S., approximately 600,000 hysterectomies are performed annually, with many cases due to fibroids. Additionally, the demand for minimally invasive procedures promotes faster recovery and shorter hospital stays. Hospitals and surgical centers are also key contributors, performing a high volume of procedures and adopting new technologies.
Growth Drivers:
- Rising Uterine Fibroids Prevalence: Increasing gynecological disorders are driving demand for morcellator-assisted minimally invasive surgeries.
- Adoption of Minimally Invasive Surgeries: Patients favor shorter recovery times and lower costs, thereby increasing the use of laparoscopic procedures.
- Advancements in Morcellation Systems: Innovations in enclosed devices enhance safety and market confidence.
- Expanding Healthcare Infrastructure: Growth of hospitals and surgical centers in emerging markets presents new opportunities.
Key Trends:
- Shift to Enclosed Morcellation Systems: FDA guidelines are pushing for devices that prevent tissue dispersion during surgery.
- Integration of Robotic Morcellation: Robotic systems enhance precision and improve outcomes.
- Demand for Single-Use Morcellators: Concerns about infections drive the need for disposable devices.
- Rising R&D Investment: Companies are investing in next-gen morcellators with advanced safety features.
Market Segmentation and Key Players:
The Morcellators Market is segmented by product type into Manual Morcellators and Power Morcellators (including Laparoscopic and Hysteroscopic variants), by application into Laparoscopy, Hysterectomy, Uterine Myomectomy, and other applications, and by end user across Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and other end users. Regionally, the market spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with Asia-Pacific projected to have the highest CAGR of approximately 10%, driven by the expansion of healthcare infrastructure in China, India, Japan, and South Korea. Comprehensive segmentation details are provided in the Segmentation section below.
Major companies operating in the Morcellators Market include Medtronic, which holds approximately 28% market share with advanced power morcellators; Olympus Corporation, known for its moresolution™ Power Morcellator; and Johnson & Johnson, which is restructuring its medical technology portfolio to enhance its surgical device offerings.
Research Methodology:
The research methodology for the Morcellators Market by FutureWise Research involves primary and secondary research, including expert interviews and data from healthcare journals and company reports. Findings are validated through data triangulation and market size estimation, using frameworks such as Porter's Five Forces and PESTEL analysis to produce reliable forecasts for 2026 to 2036.